COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 248: Articles 2471-2480  | Next

COVID-19 vaccines as boosters or first doses: Simulating scenarios to minimize infections and deaths.
El Deeb, O., El Khoury Edde, J.
10.1101/2024.04.12.24305705 — Posted: 2024-04-12
Parametrization of Worldwide Covid-19 data for multiple variants: How is the SAR-Cov2 virus evolving?
Foerster, D., Bhatkar, S., Bhanot, G.
10.1101/2024.04.09.24305557 — Posted: 2024-04-12
MONITORING OF RESPIRATORY VIRUS COINFECTION IN SOUTHERN BRAZIL DURING COVID-19 PANDEMIC
Padilha, D. A., Barazzetti, F. H., Schorner, M. A., Filho, V. B., Kawagoe, E. K., Souza, D. S. M., Bazzo, M. L., Wagner, G., Fongaro, G.
10.1101/2024.04.09.24305542 — Posted: 2024-04-12
Cardiovascular symptoms of PASC are associated with trace-level cytokines that affect the function of human pluripotent stem cell derived cardiomyocytes
Sinclair, J., Vedelago, C., Ryan, F., Carney, M., Redd, M., Lynn, M., Grubor-Bauk, B., Cao, Y., Henders, A., Chew, K. Y., Gilroy, D., Greaves, K., Labzin, L., Ziser, L., Ronacher, K., Wallace, L., Zhang, Y., Macauslane, K., Ellis, D., Rao, S., Burr, L., Bain, A., Schulz, B. L., Li, J., Lynn, D. J., Palpant, N., Wuethrich, A., Trau, M., Short, K.
10.1101/2024.04.11.587623 — Posted: 2024-04-12
Coatomer complex I is required for the transport of SARS-CoV-2 progeny virions from the endoplasmic reticulum-Golgi intermediate compartment
Hirbayashi, A., Muramoto, Y., Takenaga, T., Tsunoda, Y., Wakazaki, M., Sato, M., Fujita-Fujiharu, Y., Nomura, N., Yamauchi, K., Onishi, C., Nakano, M., Toyooka, K., Noda, T.
10.1101/2024.04.10.588984 — Posted: 2024-04-11
Microgliosis, astrogliosis and loss of aquaporin-4 polarity in frontal cortex of COVID-19 patients
Beiersdorfer, A., Rotermund, N., Schulz, K., Busch, M., Hirnet, D., Henne, S., Schwarzenberg, F., Dottermusch, M., Ondruschka, B., Matschke, J., Wuelfing, C., Glatzel, M., Lohr, C.
10.1101/2024.04.10.588851 — Posted: 2024-04-11
A narrow ratio of nucleic acid to SARS-CoV-2 N-protein enables phase separation
Laughlin, P. M., Young, K., Wang, J. C.-Y., Gonzalez-Gutierrez, G., Zlotnick, A.
10.1101/2024.04.10.588883 — Posted: 2024-04-11
N-protein vaccine Convacell(R) is effective against COVID-19: phase 3, randomized, double-blind, placebo-controlled clinical trial
Rabdano, S. O., Ruzanova, E. A., Vertyachikh, A. E., Teplykh, V. A., Emelyanova, A. B., Rudakov, G. O., Arakelov, S. A., Pletyukhina, I. V., Saveliev, N. S., Lukovenko, A. A., Fakhretdinova, L. N., Safi, A. S., Zhirenkina, E. N., Polyakova, I. N., Belozerova, N. S., Klykov, V. V., Savelieva, A. P., Ekimov, A. A., Merkulov, V. A., Yudin, S. M., Kruchko, D. S., Berzin, I. A., Skvortsova, V. I., Clinical Trial Group
10.1101/2024.04.01.24304717 — Posted: 2024-04-09
Integrative Systems Immunology Analysis Reveals Elevated Anti-AGTR1 Levels with Accumulating COVID-19 Symptoms
Fonseca, D. L. M., Japel, M., Filgueiras, I. S., Baiochi, G. C., Ostrinski, Y., Halpert, G., Lavi, Y. B., Vojdani, E., e Silva, J. C. S., Usuda, J. N., Freire, P. P., Nobile, A. L., Adri, A. S., Marcal, P. B., Correa, Y. L. G., do Vale, F. Y. N., Lopes, L. O., Schmidt, S. L., Wang, X., Vahldieck, C., Fels, B., Schimke, L. F., Hirata, M. H., Miranda, G. C., AKhan, T. A., Catar, R., Moll, G., Silva-Sousa, T., Yu, Y.-R. A., Dalmolin, R. J., Amital, H., Vojdani, A., Nakaya, H., Ochs, H. D., Silverberg, J. I., Zimmerman, J., Zyskind, I., Rosenberg, A. Z., Schulze-Forster, K., Heidecke, H., Hackel
10.1101/2024.04.05.24305287 — Posted: 2024-04-09
Comparative Application of the Fluctuation Test to the data of Morbidity by COVID-19 in United States of America, United Kingdom, Taiwan and China 2020-2023
Lopez, A. Y., Grassi, H. C., Andrades, E. J., Andrades, J. E.
10.1101/2024.04.06.24305422 — Posted: 2024-04-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).